Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ZINEB A AMMOUS

Allopathic & Osteopathic Physicians Medical Genetics Clinical Genetics (M.D.)

NPI
1174751218
CMS profile
1137152
Location
TOPEKA, IN

General Payments · PY2018–2024

$44,135.08

  • Reported across 100 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$10,497.44

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $9,289.68 5
Food and Beverage $678.44 8
Travel and Lodging $529.32 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,676.49 18
PY2019 $6,070.51 17
PY2020 $6,025.16 14
PY2021 $7,250.59 13
PY2022 $2,400.00 5
PY2023 $10,214.89 19
PY2024 $10,497.44 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amicus Therapeutics, Inc. $31.27 03/13/2024 Food and Beverage Undisputed 01/23/2026 1148420699 CMS
BioMarin Pharmaceutical Inc. $98.74 03/13/2024 Food and Beverage Undisputed 01/23/2026 1127060463 CMS
BioMarin Pharmaceutical Inc. $2,967.18 12/31/2024 Consulting Fee Undisputed 01/23/2026 1127057977 CMS
Genentech USA, Inc. $146.67 06/24/2024 Food and Beverage Undisputed 01/23/2026 1133136982 CMS
Mirum Pharmaceuticals, Inc. $138.41 10/04/2024 Food and Beverage Undisputed 01/23/2026 1123325761 CMS
Mirum Pharmaceuticals, Inc. $197.48 10/05/2024 Food and Beverage Undisputed 01/23/2026 1123325763 CMS
Mirum Pharmaceuticals, Inc. $529.32 10/05/2024 Travel and Lodging Undisputed 01/23/2026 1123325765 CMS
Mirum Pharmaceuticals, Inc. $212.50 10/21/2024 Consulting Fee Undisputed 01/23/2026 1123325755 CMS
Mirum Pharmaceuticals, Inc. $3,400.00 11/04/2024 Consulting Fee Undisputed 01/23/2026 1123325757 CMS
Mirum Pharmaceuticals, Inc. $770.00 12/10/2024 Consulting Fee Undisputed 01/23/2026 1123325759 CMS
ModernaTX, Inc. $1,940.00 07/10/2024 Consulting Fee Undisputed 01/23/2026 1152558998 CMS
Takeda Pharmaceuticals U.S.A., Inc. $26.64 06/06/2024 Food and Beverage Undisputed 01/23/2026 1137470486 CMS
Ultragenyx Pharmaceutical Inc. $19.31 06/21/2024 Food and Beverage Undisputed 01/23/2026 1153289547 CMS
Zevra Therapeutics Inc $19.92 08/29/2024 Food and Beverage Undisputed 01/23/2026 1119595537 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.